![Patrick Fabbio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 287 955 $ in data 30/06/2026
Patrick Fabbio currently works at BeyondSpring, Inc., as Independent Director from 2018 and Protara Therapeutics, Inc., as Chief Financial Officer from 2023.
Mr. Fabbio also formerly worked at NPS Pharmaceuticals, Inc., as Vice President-Finance from 2012 to 2015, Biomatrix, Inc., as Controller, Progenics Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Senior VP, Ikano Therapeutics, Inc., as Chief Financial Officer from 2009 to 2011, Coopers & Lybrand (London), as Auditor, Catalent Pharma Solutions, Inc., as Vice President-Finance, Innovation & Growth, electroCore, Inc., as Chief Financial Officer, WindMIL Therapeutics, Inc., as Chief Financial Officer from 2020 to 2021, and Rafael Holdings, Inc., as Chief Financial & Accounting Officer in 2023.
Mr. Fabbio received his undergraduate degree from Pace University and Masters Business Admin degree from The Leonard N Stern School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 26/01/2026 | 64.115 ( 0,11% ) | 244 919 $ | 30/06/2026 | |
BEYONDSPRING INC. 0,06% | 01/04/2026 | 24.592 ( 0,06% ) | 43 036 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BEYONDSPRING INC. | Direttore/Membro del Consiglio | 02/01/2018 |
| PROTARA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 30/01/2023 |
| Società | Posizione | Fine |
|---|---|---|
| RAFAEL HOLDINGS, INC. | Presidente | 01/01/2023 |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Direttore Finanziario/CFO | 01/09/2021 |
| PROGENICS PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 27/03/2020 |
| NPS PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/05/2015 |
Ikano Therapeutics, Inc.
 Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direttore Finanziario/CFO | 18/01/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Biomatrix, Inc.
 Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets viscoelastic products | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Ikano Therapeutics, Inc.
Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coopers & Lybrand (London)
 Coopers & Lybrand (London) Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
electroCore, Inc.
 electroCore, Inc. Medical SpecialtiesHealth Technology Develops non-invasive neuromodulation therapies | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
BeyondSpring, Inc.
 BeyondSpring, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cancer therapies | Health Technology |
Rafael Holdings, Inc.
 Rafael Holdings, Inc. Real Estate DevelopmentFinance Operates as holding company with interest in real estate and pharmaceutical sector | Finance |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
